EP3867244
4-pýrasín-2-ýlmetýl-morfólínafleiður og notkunin þeirra sem lyf
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.10.2019EP published:
18.1.2023EP application number:
19786343.4
EP translation filed:
6.3.2023Grant published:
15.4.2023EPO information:
European Patent Register
Max expiry date:
15.10.2039Expiry date:
15.10.2026Next due date:
31.10.2026
Title in English:
4-PYRAZIN-2-YLMETHYL-MORPHOLINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTLanguage of the patent:
English
Timeline
Today
16.10.2019EP application
18.1.2023EP Publication
6.3.2023Translation submitted
15.4.2023Registration published
15.10.2026Expires
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
GIOVANNINI, RiccardoAddress:
55216 Ingelheim am Rhein, DE
Name:
CECI, AngeloAddress:
55216 Ingelheim am Rhein, DE
Name:
DORNER-CIOSSEK, CorneliaAddress:
55216 Ingelheim am Rhein, DE
Name:
PFAU, RolandAddress:
55216 Ingelheim am Rhein, DE
Name:
WIEDENMAYER, DieterAddress:
55216 Ingelheim am Rhein, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
18200943Date:
17.10.2018Country:
EP
Classification
Categories:
C07D 405/10, A61P 25/24, A61K 31/506
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 10.10.2023
Expires: 15.10.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 6
Paid: 10.10.2024
Expires: 15.10.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 13.10.2025
Expires: 15.10.2026
Payer: G.H. Sigurgeirsson ehf.